Safety of magnetic resonance imaging in patients with cardiovascular devices - An American Heart Association scientific statement from the committee on diagnostic and interventional cardiac catheterization, council on clinical cardiology, and the council on cardiovascular radiology and intervention

被引:324
作者
Levine, Glenn N. [1 ]
Gomes, Antoinette S. [1 ]
Arai, Andrew E. [1 ]
Bluemke, David A. [1 ]
Flamm, Scott D. [1 ]
Kanal, Emanuel [1 ]
Manning, Warren J. [1 ]
Martin, Edward T. [1 ]
Smith, J. Michael [1 ]
Wilke, Norbert [1 ]
Shellock, Frank S. [1 ]
机构
[1] Amer Coll Cardiol Fdn, N Amer Soc Cardiac Imaging, Soc Cardiovasc Magnet Resonance, Bethesda, MD 20814 USA
关键词
AHA Scientific Statement; magnetic resonance imaging; cardiovascular devices;
D O I
10.1161/CIRCULATIONAHA.107.187256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Advances in magnetic resonance (MR) imaging over the past 2 decades have led to MR becoming an increasingly attractive imaging modality. With the growing number of patients treated with permanent implanted or temporary cardiovascular devices, it is becoming ever more important to clarify safety issues in regard to the performance of MR examinations in patients with these devices. Extensive, although not complete, ex vivo, animal, and clinical data are available from which to generate recommendations regarding the safe performance of MR examination in patients with cardiovascular devices, as well as to ascertain caveats and contraindications regarding MR examination for such patients. Safe MR imaging involves a careful initial patient screening, accurate determination of the permanent implanted or temporary cardiovascular device and its properties, a thoughtful analysis of the risks and benefits of performing the examination at that time, and, when indicated, appropriate physician management and supervision. This scientific statement is intended to summarize and clarify issues regarding the safety of MR imaging in patients with cardiovascular devices.
引用
收藏
页码:2878 / 2891
页数:14
相关论文
共 108 条
  • [1] Effects of magnetic resonance Imaging on cardiac pacemakers and electrodes
    Achenbach, S
    Moshage, W
    Diem, B
    Bieberle, T
    Schibgilla, V
    Bachmann, K
    [J]. AMERICAN HEART JOURNAL, 1997, 134 (03) : 467 - 473
  • [2] ADMED S, 2001, J CARDIOVASC MAGN R, V3, P171
  • [3] [Anonymous], F250305 ASTM
  • [4] Avery J K, 1988, J Tenn Med Assoc, V81, P523
  • [5] Improved lumen visualization in metallic vascular implants by reducing RF artifacts
    Bartels, LW
    Bakker, CJG
    Viergever, MA
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2002, 47 (01) : 171 - 180
  • [6] MRI safety aspects and artifacts of atrial septal defect and patent foramen ovale occluders at 1.5 Tesla: A phantom study
    Bock, M
    Mohrs, OK
    Voigtlaender, T
    Kauczor, HU
    Semmler, W
    [J]. ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2006, 178 (03): : 272 - 277
  • [7] Real-time MR guidance for inferior vena cava filter placement in an animal model
    Bücker, A
    Neuerburg, JM
    Adam, GB
    Glowinski, A
    Schaeffter, T
    Rasche, V
    van Vaals, JJ
    Günther, RW
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2001, 12 (06) : 753 - 756
  • [8] Condon B, 2000, J MAGN RESON IMAGING, V12, P171, DOI 10.1002/1522-2586(200007)12:1<171::AID-JMRI19>3.0.CO
  • [9] 2-W
  • [10] Is magnetic resonance imaging safe in cardiac pacemaker recipients?
    Del Ojo, JL
    Moya, F
    Villalba, J
    Sanz, O
    Pavón, R
    Garcia, D
    Pastor, L
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (04): : 274 - 278